Skip to content

The effect of ROY compatibility model on care resiliency and suffering in mothers of children treated with chemotherapy

The effect of ROY compatibility model on care resiliency and suffering in mothers of children treated with chemotherapy

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20170512033932N2
Enrollment
30
Registered
2018-03-07
Start date
2018-03-03
Completion date
Unknown
Last updated
2018-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of ROY compatibility model on care resiliency and Care suffering.

Interventions

Intervention 1: Intervention group: The intervention group included the necessary education in the field of cancer, education of physiological needs regarding nutrition and sleep, self concept educati

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: having a child with cancer having a willingness to participate in this study at least reading and writing skills having at least one chemotherapy session.

Exclusion criteria

Exclusion criteria: Participants who were reluctant to continue participating in the study who were absent more than one session deleted from the study

Design outcomes

Primary

MeasureTime frame
Scores of Resiliency of the 25 questionnaire of Conver and Davidson Resiliency. Timepoint: Before the intervention begins and after intervention (STAI). Method of measurement: Based on total score of total Resiliency.

Secondary

MeasureTime frame
Questionnaire 22 questions of care suffering. Timepoint: Before the intervention begins and after intervention. Method of measurement: Based on the total score of care suffering.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFariba Hatami

Islamic Azad University

hatamifariba577@gmail.com+98 17 3232 5379

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026